Detalhe da pesquisa
1.
Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses.
Immunity
; 56(6): 1341-1358.e11, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37315536
2.
PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells.
Nature
; 629(8011): 417-425, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658748
3.
A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity.
Cancer Cell
; 41(8): 1498-1515.e10, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451271